MetaADEDB 2.0 @ LMMD
Nebivolol
(KOHIRBRYDXPAMZ-YHBROIRLSA-N)
Structure
SMILES
O[C@@H]([C@@H]1CCc2c(O1)ccc(c2)F)CNC[C@H]([C@H]1CCc2c(O1)ccc(c2)F)O
Molecular Formula:
C22H25F2NO4
Molecular Weight:
405.435
Log P:
2.7545
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
3
TPSA:
70.95
CAS Number(s):
118457-14-0; 118457-15-1
Synonym(s)
1.
Nebivolol
2.
Alpha,Alpha'-(Iminobis(Methylene))bis(6-Fluoro-3,4-dihydro)-2H-1-benzopyran-2-methanol
3.
Bystolic
4.
Lobivon
5.
Nebilet
6.
Nebivolol Hydrochloride
7.
R 67555
8.
R-67555
9.
Silostar
10.
67555, R
11.
Hydrochloride, Nebivolol
12.
R67555
External Link(s)
MeSHD000068577
PubChem Compound189562
ChEBI64021
CHEMBLCHEMBL3526436
ZINC3951631
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1FatigueFAERS: 71US FAERS
2DizzinessFAERS: 60US FAERS
3BradycardiaFAERS: 48US FAERS
4HeadacheFAERS: 45US FAERS
5Drug ineffectiveFAERS: 31US FAERS
6AlopeciaFAERS: 29US FAERS
7NauseaFAERS: 29US FAERS
8Chest PainFAERS: 24US FAERS
9Wrong technique in product usage processFAERS: 24US FAERS
10PalpitationsFAERS: 22US FAERS
11Feeling abnormalFAERS: 21US FAERS
12PruritusFAERS: 19US FAERS
13HypersensitivityFAERS: 16US FAERS
14MalaiseFAERS: 16US FAERS
15HypotensionFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
16Intentional product misuseFAERS: 14US FAERS
17UrticariaFAERS: 13US FAERS
18ArthralgiaFAERS: 12US FAERS
19Unevaluable eventFAERS: 12US FAERS
20Abdominal PainFAERS: 11US FAERS
21PainFAERS: 11US FAERS
22Drug dose omissionFAERS: 10US FAERS
23DyspepsiaFAERS: 10US FAERS
24AstheniaFAERS: 9US FAERS
25Erectile dysfunctionFAERS: 9US FAERS
26Visual ImpairmentFAERS: 9US FAERS
27Abdominal discomfortFAERS: 8US FAERS
28AnxietyFAERS: 8US FAERS
29Cerebrovascular accidentFAERS: 8US FAERS
30Chest discomfortFAERS: 8US FAERS
31FlatulenceFAERS: 8US FAERS
32Peripheral swellingFAERS: 8US FAERS
33SomnolenceFAERS: 8US FAERS
34TremorFAERS: 8US FAERS
35Joint swellingFAERS: 7US FAERS
36Memory impairmentFAERS: 7US FAERS
37MyalgiaFAERS: 7US FAERS
38SyncopeFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
39AngioedemaFAERS: 6US FAERS
40Atrial FibrillationFAERS: 6US FAERS
41Atrioventricular BlockFAERS: 6US FAERS
42Blood pressure fluctuationFAERS: 6US FAERS
43ConstipationFAERS: 6US FAERS
44Expired product administeredFAERS: 6US FAERS
45FlushingFAERS: 6US FAERS
46TinnitusFAERS: 6US FAERS
47VomitingFAERS: 6US FAERS
48Weight decreasedFAERS: 6US FAERS
49AsthmaFAERS: 5US FAERS
50Back PainFAERS: 5US FAERS
51Blood glucose increasedFAERS: 5US FAERS
52BronchospasmFAERS: 5US FAERS
53DysgeusiaFAERS: 5US FAERS
54Inappropriate schedule of drug administrationFAERS: 5US FAERS
55LethargyFAERS: 5US FAERS
56Musculoskeletal PainFAERS: 5US FAERS
57Myocardial InfarctionFAERS: 5US FAERS
58Neck PainFAERS: 5US FAERS
59NervousnessFAERS: 5US FAERS
60NocturiaFAERS: 5US FAERS
61SwellingFAERS: 5US FAERS
62AgitationFAERS: 4US FAERS
63BronchitisFAERS: 4US FAERS
64ErythemaFAERS: 4US FAERS
65Feeling jitteryFAERS: 4US FAERS
66Malignant HypertensionFAERS: 4US FAERS
67Musculoskeletal stiffnessFAERS: 4US FAERS
68PneumoniaFAERS: 4US FAERS
69Therapeutic response unexpectedFAERS: 4US FAERS
70VertigoFAERS: 4US FAERS
71Accidental exposure to product by childFAERS: 3US FAERS
72Adverse eventFAERS: 3US FAERS
73Blood pressure inadequately controlledFAERS: 3US FAERS
74Blood triglycerides increasedFAERS: 3US FAERS
75Cardiac ArrestFAERS: 3US FAERS
76ChromaturiaFAERS: 3US FAERS
77DiscomfortFAERS: 3US FAERS
78Drug dispensing errorFAERS: 3US FAERS
79Drug prescribing errorFAERS: 3US FAERS
80Feeling ColdFAERS: 3US FAERS
81Gastrointestinal PainFAERS: 3US FAERS
82Head discomfortFAERS: 3US FAERS
83Incorrect dose administeredFAERS: 3US FAERS
84Joint injuryFAERS: 3US FAERS
85No adverse eventFAERS: 3US FAERS
86Oropharyngeal painFAERS: 3US FAERS
87PolymyositisFAERS: 3US FAERS
88Product dose omissionFAERS: 3US FAERS
89Product storage errorFAERS: 3US FAERS
90Rash erythematousFAERS: 3US FAERS
91Suicide attemptFAERS: 3US FAERS
92TachycardiaFAERS: 3US FAERS
93Throat irritationFAERS: 3US FAERS
94ThrombocytopeniaFAERS: 3US FAERS
95WheezingFAERS: 3US FAERS
96jaundiceFAERS: 3US FAERS
97Accidental overdoseFAERS: 2US FAERS
98Acute kidney injuryFAERS: 2US FAERS
99AmnesiaFAERS: 2US FAERS
100AngerFAERS: 2US FAERS
101Angina PectorisFAERS: 2US FAERS
102Blood potassium increasedFAERS: 2US FAERS
103Blood urine presentFAERS: 2US FAERS
104Cardiac FlutterFAERS: 2US FAERS
105ChillsFAERS: 2US FAERS
106ChokingFAERS: 2US FAERS
107Cold sweatFAERS: 2US FAERS
108DeafnessFAERS: 2US FAERS
109DehydrationFAERS: 2US FAERS
110DysphoniaFAERS: 2US FAERS
111DysuriaFAERS: 2US FAERS
112Ear congestionFAERS: 2US FAERS
113EpistaxisFAERS: 2US FAERS
114Facial PainFAERS: 2US FAERS
115Failure of child resistant mechanism for pharmaceutical productFAERS: 2US FAERS
116HemiparesisFAERS: 2US FAERS
117Impaired gastric emptyingFAERS: 2US FAERS
118Impaired work abilityFAERS: 2US FAERS
119Lactose IntoleranceFAERS: 2US FAERS
120Limb discomfortFAERS: 2US FAERS
121Low density lipoprotein increasedFAERS: 2US FAERS
122Lung InjuryFAERS: 2US FAERS
123Lupus-like syndromeFAERS: 2US FAERS
124MalnutritionFAERS: 2US FAERS
125Mental impairmentFAERS: 2US FAERS
126Middle insomniaFAERS: 2US FAERS
127Muscle tightnessFAERS: 2US FAERS
128Night sweatsFAERS: 2US FAERS
129OverdoseFAERS: 2US FAERS
130Product physical issueFAERS: 2US FAERS
131Product prescribing errorFAERS: 2US FAERS
132Product quality issueFAERS: 2US FAERS
133PsoriasisFAERS: 2US FAERS
134Sexual DysfunctionFAERS: 2US FAERS
135Skin reactionFAERS: 2US FAERS
136SluggishnessFAERS: 2US FAERS
137Stevens-Johnson SyndromeFAERS: 2US FAERS
138TrichorrhexisFAERS: 2US FAERS
139AbasiaFAERS: 1US FAERS
140Accidental exposureFAERS: 1US FAERS
141Activities of daily living impairedFAERS: 1US FAERS
142Alanine Aminotransferase IncreasedFAERS: 1US FAERS
143Alcohol IntoleranceFAERS: 1US FAERS
144AnorexiaFAERS: 1US FAERS
145Anticonvulsant drug level increasedFAERS: 1US FAERS
146ApathyFAERS: 1US FAERS
147AphagiaFAERS: 1US FAERS
148ArthritisFAERS: 1US FAERS
149ArthropathyFAERS: 1US FAERS
150AscitesFAERS: 1US FAERS
151Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
152AsthenopiaFAERS: 1US FAERS
153BedriddenFAERS: 1US FAERS
154Biopsy small intestine abnormalFAERS: 1US FAERS
155BlepharospasmFAERS: 1US FAERS
156BlindnessFAERS: 1US FAERS
157Blood alkaline phosphatase increasedFAERS: 1US FAERS
158Blood cholesterol increasedFAERS: 1US FAERS
159Blood cortisol decreasedFAERS: 1US FAERS
160Blood creatinine increasedFAERS: 1US FAERS
161Blood glucose decreasedFAERS: 1US FAERS
162Blood sodium decreasedFAERS: 1US FAERS
163Blood triglyceridesFAERS: 1US FAERS
164Blood urea increasedFAERS: 1US FAERS
165Blue Toe SyndromeFAERS: 1US FAERS
166Burning sensationFAERS: 1US FAERS
167Cerebral disorderFAERS: 1US FAERS
168CholestasisFAERS: 1US FAERS
169Cholestatic liver injuryFAERS: 1US FAERS
170Completed SuicideFAERS: 1US FAERS
171CryingFAERS: 1US FAERS
172DementiaFAERS: 1US FAERS
173Depressed Level of ConsciousnessFAERS: 1US FAERS
174Device malfunctionFAERS: 1US FAERS
175Diabetes MellitusFAERS: 1US FAERS
176Diastolic dysfunctionFAERS: 1US FAERS
177DisorientationFAERS: 1US FAERS
178DissociationFAERS: 1US FAERS
179DiverticulitisFAERS: 1US FAERS
180Drug administration errorFAERS: 1US FAERS
181Dry skinFAERS: 1US FAERS
182Ear discomfortFAERS: 1US FAERS
183Eating disorder symptomFAERS: 1US FAERS
184Economic problemFAERS: 1US FAERS
185Emotional distressFAERS: 1US FAERS
186Erection increasedFAERS: 1US FAERS
187EructationFAERS: 1US FAERS
188ExophthalmosFAERS: 1US FAERS
189Extra dose administeredFAERS: 1US FAERS
190Gait inabilityFAERS: 1US FAERS
191GoutFAERS: 1US FAERS
192Hepatic necrosisFAERS: 1US FAERS
193Hepatitis AFAERS: 1US FAERS
194HepatitisFAERS: 1US FAERS
195HostilityFAERS: 1US FAERS
196HypersomniaFAERS: 1US FAERS
197Iatrogenic injuryFAERS: 1US FAERS
198Impaired driving abilityFAERS: 1US FAERS
199Inappropriate schedule of product administrationFAERS: 1US FAERS
200Intentional dose omissionFAERS: 1US FAERS
201Intentional product use issueFAERS: 1US FAERS
202Intercepted product storage errorFAERS: 1US FAERS
203Intestinal villi atrophyFAERS: 1US FAERS
204Irritable Bowel SyndromeFAERS: 1US FAERS
205Labile blood pressureFAERS: 1US FAERS
206Left Ventricular HypertrophyFAERS: 1US FAERS
207Lip swellingFAERS: 1US FAERS
208LymphadenopathyFAERS: 1US FAERS
209Macular degenerationFAERS: 1US FAERS
210Mallory-Weiss SyndromeFAERS: 1US FAERS
211Medication ErrorFAERS: 1US FAERS
212Metastases to adrenalsFAERS: 1US FAERS
213Micturition frequency decreasedFAERS: 1US FAERS
214Mouth swellingFAERS: 1US FAERS
215Musculoskeletal discomfortFAERS: 1US FAERS
216NoduleFAERS: 1US FAERS
217Noninfective gingivitisFAERS: 1US FAERS
218OnychoclasisFAERS: 1US FAERS
219OnycholysisFAERS: 1US FAERS
220OnychomycosisFAERS: 1US FAERS
221Oral candidiasisFAERS: 1US FAERS
222Oral mucosal eruptionFAERS: 1US FAERS
223Oral mucosal erythemaFAERS: 1US FAERS
224Oral painFAERS: 1US FAERS
225OverweightFAERS: 1US FAERS
226Performance status decreasedFAERS: 1US FAERS
227PericarditisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
228Personality ChangeFAERS: 1US FAERS
229PleurisyFAERS: 1US FAERS
230Poor peripheral circulationFAERS: 1US FAERS
231Poor quality sleepFAERS: 1US FAERS
232Portal HypertensionFAERS: 1US FAERS
233Post procedural complicationFAERS: 1US FAERS
234PregnancyFAERS: 1US FAERS
235PresyncopeFAERS: 1US FAERS
236PriapismFAERS: 1US FAERS
237Product dispensing errorFAERS: 1US FAERS
238Product label issueFAERS: 1US FAERS
239Product packaging confusionFAERS: 1US FAERS
240Product packaging issueFAERS: 1US FAERS
241Product packaging quantity issueFAERS: 1US FAERS
242Product substitution issueFAERS: 1US FAERS
243Product taste abnormalFAERS: 1US FAERS
244Product use issueFAERS: 1US FAERS
245Quality of life decreasedFAERS: 1US FAERS
246Respiratory arrestFAERS: 1US FAERS
247RetchingFAERS: 1US FAERS
248Retinal Artery OcclusionFAERS: 1US FAERS
249Rheumatoid ArthritisFAERS: 1US FAERS
250SclerodermaFAERS: 1US FAERS
251Sick Sinus SyndromeFAERS: 1US FAERS
252SomnambulismFAERS: 1US FAERS
253StomatitisFAERS: 1US FAERS
254StressFAERS: 1US FAERS
255SunburnFAERS: 1US FAERS
256TensionFAERS: 1US FAERS
257Therapy regimen changedFAERS: 1US FAERS
258ThrombosisFAERS: 1US FAERS
259Tongue blisteringFAERS: 1US FAERS
260Tongue discomfortFAERS: 1US FAERS
261Tongue erythemaFAERS: 1US FAERS
262ToothacheFAERS: 1US FAERS
263Unresponsive to stimuliFAERS: 1US FAERS
264Urinary RetentionFAERS: 1US FAERS
265Withdrawal hypertensionFAERS: 1US FAERS
266nervous system disorderFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.